New

Global ETF Survey 2026: Answer now →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

Global ETF Survey 2026
ETF IssuersiShares2B77
2B77

iShares Ageing Population UCITS ETF

The 2B77 Exchange Traded Fund (ETF) is provided by iShares. It is built to track an index: STOXX Global Ageing Population Index. The 2B77 ETF provides physical exposure, so by buying it you actually own parts of all the 350 underlying holdings. The dividend policy is capitalization.

Advertisement

Advertisement

$10.99
N/A
Data as of 08/14/26
1D price range
N/A
52W price range
$8.82$10.99
YTD Perf.
+15.30%
YTD Flows
Annualized volatility
Fund AuM
€812M
Share class AuM
€812M
TTM Yield
-
Tracking Error
Tracking Difference
ISIN
IE00BYZK4669
TER
0.4%
Inception date
9/8/2016
Issuer
Replication method
Dividend policy
Compare similar ETFs

No content available for this fund

API
PerformanceDec 31, 2025 - Aug 14, 2026
-5%0%5%10%15%JANMARMAYJUL
Flows
Join for free to unlock
Data as of 06/30/26
Healthcare
49.09%
Finance
42.61%
Consumer Services
3.79%
Consumer Non-Cyclicals
1.87%
Consumer Cyclicals
1.83%
Unavailable
0.20%
Other
0.60%
Latest 2B77 news

No content available for this fund

FAQ about 2B77

2B77 is a Passive ETF. This ETF provides exposure to Other Equities.
2B77 tracks the STOXX Global Ageing Population Index - USD, through a optimized sampling replication method.
2B77 carries a total expense ratio (TER) of 0.4%, indicating the annual cost for holding the fund.
2B77 was introduced to the market on September 8, 2016. It trades on Germany, among other exchanges
iShares Ageing Population UCITS ETF, 2B77, is provided by iShares. Learn more about iShares here.
2B77 oversees €812M in assets as of August 14, 2026.
2B77 follows a capitalizing, meaning it reinvests income within the fund.
As of June 30, 2026, 2B77 has significant geographic allocations in USA, Japan and United Kingdom.
As of June 30, 2026, 2B77 focuses largely on Healthcare, Finance and Consumer Services.
As of June 30, 2026, 2B77 holds 350 positions in its portfolio, with 8.60% of assets concentrated in its top 15 holdings.
As of June 30, 2026, 2B77 top three holdings include PharmaEssentia Corp., Cytokinetics, Inc. and Instl. Cash Ser. - BlackRock ICS (USD) Liquidity Fund.
The base currency of 2B77 is USD.
Data as of 06/30/26
PharmaEssentia Corp.
0.66%
Cytokinetics, Inc.
0.61%
Instl. Cash Ser. - BlackRock ICS (USD) Liquidity Fund
0.60%
Robinhood Markets, Inc.
0.58%
Hims & Hers Health, Inc.
0.58%
Alkermes Plc
0.58%
Protagonist Therapeutics, Inc.
0.57%
Max Healthcare Institute Ltd.
0.57%
Viking Holdings Ltd. (Bermuda)
0.56%
DaVita, Inc.
0.55%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight